Tm6sf2 silencing in mice increased hepatic fat accumulation by three-fold and decreased VLDL secretion by 50% suggesting that TM6SF2 is involved in VLDL release and that impaired TM6SF2 function may lead to NAFLD development. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.